Compare WGS & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | QS |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Auto Parts:O.E.M. |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | 2020 | 2020 |
| Metric | WGS | QS |
|---|---|---|
| Price | $69.50 | $4.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 9 |
| Target Price | ★ $93.50 | $5.41 |
| AVG Volume (30 Days) | 722.5K | ★ 13.2M |
| Earning Date | 11-09-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.37 | 19.15 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $427,539,000.00 | N/A |
| Revenue This Year | $12.70 | N/A |
| Revenue Next Year | $24.31 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.97 | N/A |
| 52 Week Low | $32.21 | $3.80 |
| 52 Week High | $170.87 | $17.86 |
| Indicator | WGS | QS |
|---|---|---|
| Relative Strength Index (RSI) | 48.91 | 38.94 |
| Support Level | $68.55 | $3.80 |
| Resistance Level | $73.04 | $4.51 |
| Average True Range (ATR) | 5.62 | 0.25 |
| MACD | 0.96 | 0.04 |
| Stochastic Oscillator | 81.47 | 26.76 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional nodes. The company operates in one operating segment only.